OraSure Technologies (OSUR) Announces Receipt of FDA Emergency Use Authorization for OraQuick Ebola Test
OraSure Technologies (NASDAQ: OSUR) announced that it has received a U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
